Showing 317 results

Filters Content type: News, Editors' picks, About HIV Topic: Drug interactions & pharmacokinetics

Taking two or more different drugs together may result in an alteration in the effectiveness or in the side-effects of one or more of the drugs. Pharmacokinetics (PK) is the study of how a drug is absorbed into the body and distributed in different parts of the body. Pharmacodynamics (PD) is the study of the impact of different concentrations of a drug on the body.

Drug interactions & pharmacokinetics

Genetic testing for drug intolerance

Editor's pick
The Guardian
16 April 2012
New & experimental hepatitis C treatment

What You Don’t Know, You Can Sell: Merck’s Cavalier Attitude Towards the Welfare of HIV/HCV Coinfected Patients

Editor's pick
TAG
10 April 2012
Hepatitis C treatment

Studies look at interactions between new hepatitis C drugs and HIV antiretrovirals

News
14 March 2012
Malaria

Lopinavir/ritonavir cuts malaria risk in children with HIV

News
7 March 2012
Injectable & long-acting PrEP

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

News
7 March 2012
PrEP science

Four doses of PrEP a week may be enough to protect

News
6 March 2012
Drug interactions & pharmacokinetics

FDA updates guidance for use of HIV and hepatitis C protease inhibitors with statins

News
4 March 2012
Side effects

Severe nevirapine rash linked to slow clearance of drug

News
20 February 2012
New & experimental hepatitis C treatment

European Medicines Agency informs doctors and patients about drug interaction between Victrelis and ritonavir-boosted HIV protease inhibitors

Editor's pick
European Medicines Agency
18 February 2012
Hepatitis C treatment

Copy of Merck Warns of Victrelis and HIV Protease Inhibitor Interactions

Editor's pick
Kaiser Daily Global Health Policy Report
8 February 2012
Hepatitis C treatment

Merck Warns of Victrelis and HIV Protease Inhibitor Interactions

Editor's pick
AIDSMeds
8 February 2012
Drug interactions & pharmacokinetics

Combining HCV Med Boceprevir with Boosted HIV Protease Inhibitors Can Lower Drug Levels

Editor's pick
HIVandHepatitis.com
7 February 2012
Pregnancy and vertical transmission

Can speeding up nevirapine clearance reduce the risk of resistance after PMTCT use?

News
20 January 2012
Drug interactions & pharmacokinetics

Guidelines published on management of interactions between anti-epileptic and anti-HIV drugs

News
9 January 2012
Drug interactions & pharmacokinetics

Guidelines stress caution when combining anti-epileptic, HIV drugs

Editor's pick
Science Daily
4 January 2012
Drug interactions & pharmacokinetics

Guidelines stress caution when combining anti-epileptic, HIV drugs

Editor's pick
Medical Xpress
4 January 2012
New & experimental HIV treatments

BMS to develop Reyataz fixed-dose pill with Gilead booster drug

Editor's pick
MarketWatch
26 October 2011
Pharmaceutical industry

Innovative transdermal patch for delivery of HIV medicine

Editor's pick
Science Daily
25 October 2011
New & experimental hepatitis C treatment

ICAAC: HCV Drug Telaprevir Shows No Problematic Interactions with Raltegravir

Editor's pick
HIVandhepatitis.com
6 October 2011
HIV treatment for children & young people

Efavirenz may be under-dosed in children

News
5 October 2011
HIV treatment for children & young people

Crushing Kaletra tablets for kids leads to lower drug levels

News
23 September 2011
Drug interactions & pharmacokinetics

Older anti-epileptic drugs associated with failure of HIV treatment

News
2 September 2011
Drug interactions & pharmacokinetics

Varying efficacy of HIV drug cocktails explained

Editor's pick
Science News
13 July 2011
Neurological & cognitive problems

HIV disrupts blood-brain barrier: Cellular study suggests way virus may cause neurological deficits

Editor's pick
Science Daily
28 June 2011